Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.
NCT ID: NCT02157090
Last Updated: 2014-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2009-08-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate Using a Cold Sore Patch to Treat Herpes Labialis
NCT01208298
Study of a Cold Sore Patch for the Treatment of Herpes Labialis
NCT01484067
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
NCT01653509
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
NCT01971385
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
NCT00375570
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Herpes Patch SOS (Hansaplast®)
Herpes Patch SOS (Hansaplast®)
Herpes vesicle patch of Compeed®
Herpes vesicle patch of Compeed®
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Herpes Patch SOS (Hansaplast®)
Herpes vesicle patch of Compeed®
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a history of recurrent HSL of the lips and/or perioral skin
* lesions typically manifesting as classical lesions
* duration of HSL symptoms not more than three days
* haven´t used acyclovir or other cold sore therapies
Exclusion Criteria
* lactating women
* women of child-bearing age without medically secured contraceptions
* topical or systemic therapy with analgesic
* anti-inflammatory or antiviral agents within the last 2 weeks
* topical therapy within the treatment area
* systemic therapy with cytostatics or immunosuppressants
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beiersdorf AG
UNKNOWN
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Carl Gustav Carus at the Technische Universität Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Herpes patch study 32583
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.